ELTX
Elicio Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.69 / 10
Underperform
The company exhibits poor fundamental metrics (2.7/10). Strengths observed in Inventory turnover ratio and Interest coverage ratio (EBIT / Interest expense) (%), with caution warranted for PB-ROE and Asset-MV. Lead to challenging appraisal.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight30.91%
1M Return11.03%
Value-0.26
Score3/3
Weight30.91%
1M Return11.03%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.57%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.57%
1M Return-1.23%
PB-ROE
Value5.07
Score0/3
Weight8.83%
1M Return3.36%
Value5.07
Score0/3
Weight8.83%
1M Return3.36%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.23%
1M Return0.10%
Value92.79
Score2/3
Weight0.23%
1M Return0.10%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-2.11%
1M Return-0.98%
Value100.00
Score2/3
Weight-2.11%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.99%
1M Return0.88%
Value78.62
Score3/3
Weight1.99%
1M Return0.88%
Profit-MV
Value0.47
Score2/3
Weight24.81%
1M Return8.99%
Value0.47
Score2/3
Weight24.81%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.68%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.68%
1M Return-1.25%
Asset-MV
Value-0.51
Score0/3
Weight16.76%
1M Return6.58%
Value-0.51
Score0/3
Weight16.76%
1M Return6.58%
Cash-MV
Value-0.07
Score2/3
Weight23.82%
1M Return8.80%
Value-0.07
Score2/3
Weight23.82%
1M Return8.80%
Revenue-MV
Value-0.26
Score3/3
Weight30.91%
1M Return11.03%
Value-0.26
Score3/3
Weight30.91%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.99%
1M Return0.88%
Value78.62
Score3/3
Weight1.99%
1M Return0.88%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.57%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.57%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight24.81%
1M Return8.99%
Value0.47
Score2/3
Weight24.81%
1M Return8.99%
PB-ROE
Value5.07
Score0/3
Weight8.83%
1M Return3.36%
Value5.07
Score0/3
Weight8.83%
1M Return3.36%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.68%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.68%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.23%
1M Return0.10%
Value92.79
Score2/3
Weight0.23%
1M Return0.10%
Asset-MV
Value-0.51
Score0/3
Weight16.76%
1M Return6.58%
Value-0.51
Score0/3
Weight16.76%
1M Return6.58%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-2.11%
1M Return-0.98%
Value100.00
Score2/3
Weight-2.11%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight23.82%
1M Return8.80%
Value-0.07
Score2/3
Weight23.82%
1M Return8.80%
Is ELTX undervalued or overvalued?
- ELTX scores 2.69/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 0.00% net margin, -2.66 P/E ratio, 38.13 P/B ratio, and 9.59% earnings growth, these metrics solidify its Underperform investment rating.
